IMVT - CIK 0001764013
As of 2026-06-10, Immunovant, Inc. (IMVT) has a market capitalization of $6.40 B, making it the #1219 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-10 | $6.40 B |
| 2026-05-29 | $6.76 B |
| 2026-05-28 | $6.86 B |
| 2026-05-26 | $7.05 B |
| 2026-05-25 | $7.01 B |
| 2026-05-24 | $7.01 B |
| 2026-05-22 | $7.01 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-10, Immunovant, Inc. (IMVT) has a market capitalization of $6.40 B, making it the #1219 most valuable US-listed company.
Immunovant, Inc. is the #1219 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.